Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
A clinical trial update on collecting and studying tissue samples from patients with HIV-associated malignancies; the study is terminated wi…
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: Plerixafor for Poorly Mobilized Lymphoma [Phase 4]
A Phase 4 clinical trial update for plerixafor in poorly mobilized lymphoma patients is noted, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures [Phase 4]
Phase 4 trial comparing EMLA cream to lidocaine injection for pain control during lumbar punctures in pediatric oncology patients.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Continuous Infusion of rhIL-15 for Adults With Advanced Cancer [Phase 1]
Phase 1 trial updating continuous infusion of rhIL-15 in adults with advanced cancer; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F) [Phase 2]
Phase 2 MATCH subprotocol Z1F investigates copanlisib for cancers with PIK3CA mutations. Results (posted 2023-02-28) pertain to participants…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant [Phase 2]
Phase 2 trial comparing generic pegfilgrastim to brand-name pegfilgrastim for neutrophil recovery after autologous transplantation.
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma [Phase 1, Phase 2]
An early-phase clinical trial evaluating the safety and efficacy of TQB2618 injection in combination with Penpulimab for relapsed/refractory…
-
EMA withdrawal · 2023-02-10EMA Application withdrawn: Aliqopa (copanlisib dihydrochloride) — Bayer AG
The EMA has withdrawn the application for Aliqopa (copanlisib dihydrochloride) by Bayer AG for its use in lymphoma subtypes including margin…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma [Phase 2]
Phase 2 trial evaluating chemotherapy plus vaccination for mantle cell lymphoma has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL [Phase 1, Phase 2]
Phase Ib/II trial updates for copanlisib in relapsed, indolent B-cell non-Hodgkin lymphoma conducted in Japan.
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I) [Phase 2]
The National Cancer Institute provides an update on the phase 2 MATCH subprotocol evaluating taselisib (GDC-0032) in cancers with PIK3CA gen…
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B) [Phase 2]
A Phase 2 MATCH subprotocol study evaluates afatinib for cancers with HER2 genetic changes; results were posted in 2022 and the trial status…
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy [Phase 2]
Phase 2 clinical trial of haploidentical donor hematopoietic progenitor cell and natural killer (NK) cell transplantation for hematologic ma…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A clinical trial update for T3011 administered intravenously in patients with advanced solid tumors, including various cancer types, spannin…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS [Phase 3]
Phase 3 trial comparing NiCord (omidubicel) stem cell transplantation to standard umbilical cord blood in patients with hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G) [Phase 2]
Phase 2 MATCH subprotocol G trial evaluating crizotinib for cancers with ROS1 genetic changes reports updated results and current status (Ph…
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
This Phase 1 study evaluated pevonedistat in combination with irinotecan and temozolomide in patients with recurrent or refractory solid tum…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F) [Phase 2]
Phase 2 MATCH subprotocol F study evaluating crizotinib for cancers with ALK genetic changes. The trial is currently active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma [Phase 2]
Phase 2 trial of high-dose oral clarithromycin as salvage therapy in relapsed or refractory extranodal marginal zone lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies [Phase 2]
Phase 2 clinical trial evaluating cord blood with T-cell depleted haplo-identical peripheral blood stem cell transplantation for hematologic…
-
CLINICAL_TRIALS research · 2022-07-12Clinical Trial Update: Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant [Phase 1, Phase 2]
A Phase 1/2 safety study evaluating gene-modified donor T-cells after partially mismatched stem cell transplantation in patients with leukem…
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma [Phase 2]
Phase 2 clinical trial update for 6MW3211 injection in relapsed/refractory lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma [Phase 2]
Phase 2 clinical trial update for Mecapegfilgrastim (PEG-G-CSF) as prophylaxis for chemotherapy-induced neutropenia in lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies [Phase 1]
Phase 1 trial update evaluating zanubrutinib with tislelizumab in B-cell malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis [Phase 2]
Phase 2 clinical trial update on post-transplant cyclophosphamide for graft-versus-host disease prophylaxis completed; results posted in 202…